Christopher M. Jewell, Chief Scientific Officer: Cartesian Therapeutics RNAC Planned sale · Filed 01/09

Trade details

Type: Planned sale notice
Stock: Cartesian Therapeutics RNAC
Person: Christopher M. JewellChief Scientific Officer
Planned sale date: 26/01/09
Filed: 26/01/09

More to sell after $129.6K in 3 months

Cartesian Therapeutics trades, last 26 weeks

What else happened in Cartesian Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/10~02/08

Christopher M. Jewell's recent trades

Christopher M. JewellChief Scientific Officer
Planned saleCartesian Therapeutics
Planned sale
Cartesian Therapeutics
RNAC
$68.9K
9,000 sh
$68.9K
Filed 01/13
Traded 01/13
Christopher M. JewellChief Scientific Officer
Planned saleCartesian Therapeutics
Planned sale
Cartesian Therapeutics
RNAC
$192.6K
26,935 sh
$192.6K
Filed 25/11/19
Traded 25/11/19
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$21.6K
1,286 sh
$21.6K
Filed 25/01/07
Traded 25/01/06
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$21.1K
1,264 sh
$21.1K
Filed 25/01/07
Traded 25/01/03
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$303.1K
18,550 sh
$303.1K
Filed 24/11/18
Traded 24/11/14